首程控股(00697.HK)建議發行1.8億美元債券
格隆匯6月30日丨首程控股(00697.HK)宣佈,於2025年6月30日,公司與經辦人就建議發行訂立認購協議。在認購協議的條款及條件的規限下,經辦人已同意認購及支付或促使認購人認購及支付公司將予發行本金總額爲1.8億美元的債券。
公司擬將債券所得款項淨額用於投資若幹主要資產及作一般企業用途。
建議發行所得款項淨額擬主要用於主要產業的錨定投資。公司將積極尋求並把握優質投資機遇,重點聚焦於與其策略規劃契合度高的領域。通過精準的產業投資,公司旨在進一步延展及整合其產業鏈,從而提升其核心競爭力及市場佔有率。預期該等舉措將鞏固公司的行業領導地位,支持業務可持續增長,併爲股東創造更大價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.